Skip to content

Amrita guggulu and Rasonadi kwath will be given to the patient of Amavata

COMPARATIVE CLINICAL STUDY OF AMRITA GUGGULU & RASONADI KWATH IN AAMVATA - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094359
Enrollment
40
Registered
2025-09-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Sponsors

PREETI KALONI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. PATIENT WITH CLASSICAL SIGN AND SYMPTOMS OF AAMVATA 2. CHRONICITY UPTO 5 YEARS

Exclusion criteria

Exclusion criteria: 1. PATIENT WHO HAS DEVELOPED COMPLICATION OF RHEUMATOID ARTHRITIS EXAMPLE SEVERE DEFORMITY OF JOINTS AND BONES 2. CHRONICITY MORE THAN 5 YEARS 3. OSTEOARTHRITIS 4. GOUTY ARTHRITIS 5. PREGNANT AND LACTATING WOMEN 6. PATIENTS SUFFERING FROM ANY SERIOUS MEDICAL OR SURGICAL ILLNESS

Design outcomes

Primary

MeasureTime frame
RELIEF IN SUBJECTIVE PARAMETERS 1 SANDHISHOOLA (JOINT PAIN) 2 SANDHISHOTH (JOINT SWELLING) 3 SPARSHASAHATWA (TENDERNESS) 4 SANDHISTABDHATA (MORNING STIFFNESS) 5 APAKA (INDIGESTION) 6 ARUCHI 7 JWARA (FEVER) 8 GAURAVATA (HEAVINESS IN THE BODY) 9 BAHUMUTRATA (FREQUENCY OF MICTURITION) 10 UTSAHAHANI (LOSS OF VIGOUR)Timepoint: 4 weeks to 8 weeks

Secondary

MeasureTime frame
RELIEF IN OBJECTIVE PARAMETERS 1 RHEUMATOID FACTOR 2 CRP 3 ESR 4 ANTI CCP 5 RING TESTTimepoint: ASSESSMENT WILL BE DONE ON 1ST DAY 30TH DAY 60TH DAY AND 90 DAYS

Countries

India

Contacts

Public ContactPREETI KALONI

UTTARAKHAND AYURVED UNIVERSITY GURUKUL CAMPUS

pandey.punita62@gmail.com9319394485

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026